Cargando…
The effect of calcineurin inhibitors in the treatment of IgA nephropathy: A systematic review and meta-analysis (PRISMA)
BACKGROUND: Immunoglobin A nephropathy (IgAN), the most prevalent form of primary glomerulonephritis, represents the leading cause of kidney failure among East Asian populations. Immunosuppressive treatment regimen, except for a 6-month trial of corticosteroids, has not been approved by the KDIGO gu...
Autores principales: | Peng, Wei, Tang, Yi, Jiang, Zheng, Li, Zi, Mi, Xuhua, Qin, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008599/ https://www.ncbi.nlm.nih.gov/pubmed/27583915 http://dx.doi.org/10.1097/MD.0000000000004731 |
Ejemplares similares
-
Hypertension/prehypertension and its determinants in pediatric IgA nephropathy
por: Fu, Qing-Ying, et al.
Publicado: (2020) -
Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy
por: Zhai, Ya-Ling, et al.
Publicado: (2016) -
Clinicopathological analysis of IgA nephropathy combined with other glomerular diseases
por: Jiang, Lei, et al.
Publicado: (2019) -
Corticosteroids or immunosuppressants were not superior to supportive care in IgA nephropathy patients with mild proteinuria
por: Pei, Gaiqin, et al.
Publicado: (2020) -
IgA nephropathy pathogenesis and therapy: Review & updates
por: Habas, Elmukhtar, et al.
Publicado: (2022)